Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 14, 2022 09:00 ET | Source: Parexel International LLC

Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence

BOSTON and DURHAM, N.C., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the promotions of Peyton Howell to the newly-created role...
September 08, 2022 09:00 ET | Source: Parexel International LLC

Parexel Expands Network of Global Regulatory Experts

BOSTON and DURHAM, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
September 07, 2022 10:23 ET | Source: Parexel International LLC

Parexel’s Jim Anthony Named to 2022 PharmaVOICE 100

BOSTON and DURHAM, N.C., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
June 16, 2022 09:09 ET | Source: Parexel International LLC

Parexel Expands Patient Access to Clinical Trials Through New Community Alliance Network

BOSTON, and Durham, N.C., June 16, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the launch of its Community Alliance Network, a novel...
January 19, 2022 09:00 ET | Source: Parexel International LLC

Parexel Named 2022 Catalyst Award Winner

BOSTON, and DURHAM, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
January 11, 2022 15:30 ET | Source: Parexel International LLC

Parexel Recognized as “Top CRO” to Work With in WCG CenterWatch Global Site Relationship Benchmark Survey

BOSTON, and DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
January 11, 2022 09:00 ET | Source: Parexel International LLC

Parexel Bolsters Regulatory and Access Offering with Key Appointment

BOSTON, and Durham, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
January 06, 2022 09:00 ET | Source: Parexel International LLC

Parexel Releases Proprietary Biotech Market Research Report to Help Guide Companies on Navigating the Biotech Investment Landscape

BOSTON and DURHAM, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
November 15, 2021 17:03 ET | Source: Parexel International LLC

EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel

EQT Private Equity and Goldman Sachs Asset Management committed to supporting Parexel’s Patients-First focus, track record of clinical excellence and dedication to qualityNewly-appointed Board of...
October 20, 2021 09:00 ET | Source: Parexel International LLC

Parexel and Kyoto University Hospital Announce Strategic Alliance

BOSTON and DURHAM, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right